<DOC>
	<DOCNO>NCT00386581</DOCNO>
	<brief_summary>The study design investigate acute treatment efficacy , safety , tolerability atomoxetine once-daily dose strategy ( morning ) . It incorporate 6-week acute treatment period 2-week discontinuation phase . The assessment study include standard assessment ADHD symptomatology use Diagnostic Statistical Manual Mental Disorders , Fourth Editionâ„¢ , investigator-administered rating scale .</brief_summary>
	<brief_title>Efficacy , Tolerability , Safety Once-Daily Atomoxetine Hydrochloride Versus Placebo Russian Children Adolescents With Attention-Deficit/Hyperactivity Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Inclusion Criteria Subjects must ADHD meet DSMIV criterion Aged 6 16 year . Subjects must take medication use treat ADHD . Laboratory result must show significant abnormality Baseline ECG result must show abnormality Subjects must able swallow capsule . Subjects must normal intelligence . Exclusion Criteria Weigh le 20 kg 60 kg study entry . Subjects , adequate trial methylphenidate amphetamine experience benefit ADHD sign symptom exclude participate . Have history Bipolar I II disorder , psychosis , PDD . Meet DSMIV criterion anxiety disorder . Have history seizure disorder . Patients serious suicidal risk . Patients narrow angle glaucoma Subjects history severe allergy . Have history alcohol drug abuse within past 3 month Screen positive drug abuse prescribed physician . Have cardiovascular disease increase heart rate blood pressure . Have medical condition would increase sympathetic nervous system activity markedly take medication daily basis . Have severe gastrointestinal narrowing Are study time likely need psychotropic medication . Are likely begin structure psychotherapy aim ADHD symptom . Have use monoamine oxidase inhibitor ( MAOI ) 2 week Female subject pregnant breastfeeding . Are investigative site personnel directly affiliate study , immediate family investigator site personnel directly affiliate study . Are , opinion investigator , unsuitable way participate study . Are employ Lilly .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>